This post discusses the lack of evidence for the use of amiodarone in atrial fibrillation, ventricular tachycardia and cardiac arrest.
Read More
This post discusses the lack of evidence for the use of amiodarone in atrial fibrillation, ventricular tachycardia and cardiac arrest.
Read More
The current ACLS guidelines give both procainamide and amiodarone a class II recommendation as chemical therapy for the treatment of patients with stable ventricular tachycardia. Despite the fact that one drug does not appear to have an advantage over the other based on available literature,
Read More
Out-of-hospital cardiac arrest (OHCA) leads to over 300,000 deaths every year in North America. Many OHCA are due to ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT), which are generally considered to have the best prognosis during cardiac arrest due to their responsiveness to defibrillation.
Read More